Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+ T-cell responses with a long-lived effector cell phenotype
Zoltán Bánki(Innsbruck Medical University), Bart Spiesschaert(Tyrolit (Austria)), Theresa Schwaiger(University of Graz), Krishna Das(University of Liège), Dorotheé von Laer(Innsbruck Medical University), Elke Podgorschek(Tyrolit (Austria)), Brigitte Müllauer(Innsbruck Medical University), Janine Kimpel(Innsbruck Medical University), Guido Wollmann(Innsbruck Medical University), Knut Elbers, Liesa-Marie Schreiber(Innsbruck Medical University), Tobias Nolden(Tyrolit (Austria)), Andreas Aufschnaiter(University of Graz)
Cited by 9
Related Papers
Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases
|Gastroenterology|2022|303
Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2
|Science Translational Medicine|2020|260
Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S , which Encode Subcomponents C1r and C1s of Complement
|The American Journal of Human Genetics|2016|122
VOC breath profile in spontaneously breathing awake swine during Influenza A infection
|Scientific Reports|2018|78